Logo image of AVPT

AVEPOINT INC (AVPT) Stock Fundamental Analysis

USA - NASDAQ:AVPT - US0536041041 - Common Stock

14.87 USD
+0.18 (+1.23%)
Last: 10/23/2025, 8:00:01 PM
14.96 USD
+0.09 (+0.61%)
Pre-Market: 10/24/2025, 4:35:39 AM
Fundamental Rating

6

Taking everything into account, AVPT scores 6 out of 10 in our fundamental rating. AVPT was compared to 285 industry peers in the Software industry. AVPT has an excellent financial health rating, but there are some minor concerns on its profitability. AVPT is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AVPT had positive earnings in the past year.
In the past year AVPT had a positive cash flow from operations.
In the past 5 years AVPT always reported negative net income.
Of the past 5 years AVPT 4 years had a positive operating cash flow.
AVPT Yearly Net Income VS EBIT VS OCF VS FCFAVPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -1.20%, AVPT perfoms like the industry average, outperforming 55.44% of the companies in the same industry.
AVPT has a Return On Equity of -1.90%. This is comparable to the rest of the industry: AVPT outperforms 58.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.83%, AVPT is in the better half of the industry, outperforming 70.88% of the companies in the same industry.
Industry RankSector Rank
ROA -1.2%
ROE -1.9%
ROIC 3.83%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
AVPT Yearly ROA, ROE, ROICAVPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

AVPT has a better Operating Margin (6.13%) than 69.82% of its industry peers.
The Gross Margin of AVPT (74.93%) is better than 65.61% of its industry peers.
In the last couple of years the Gross Margin of AVPT has grown nicely.
Industry RankSector Rank
OM 6.13%
PM (TTM) N/A
GM 74.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
AVPT Yearly Profit, Operating, Gross MarginsAVPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVPT is destroying value.
AVPT has more shares outstanding than it did 1 year ago.
AVPT has more shares outstanding than it did 5 years ago.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AVPT Yearly Shares OutstandingAVPT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVPT Yearly Total Debt VS Total AssetsAVPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

AVPT has an Altman-Z score of 7.50. This indicates that AVPT is financially healthy and has little risk of bankruptcy at the moment.
AVPT has a Altman-Z score of 7.50. This is in the better half of the industry: AVPT outperforms 77.54% of its industry peers.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.5
ROIC/WACC0.35
WACC10.97%
AVPT Yearly LT Debt VS Equity VS FCFAVPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

AVPT has a Current Ratio of 2.37. This indicates that AVPT is financially healthy and has no problem in meeting its short term obligations.
AVPT has a better Current ratio (2.37) than 67.02% of its industry peers.
AVPT has a Quick Ratio of 2.37. This indicates that AVPT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.37, AVPT is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
AVPT Yearly Current Assets VS Current LiabilitesAVPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.00% over the past year.
AVPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.41%.
Measured over the past years, AVPT shows a very strong growth in Revenue. The Revenue has been growing by 23.27% on average per year.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)24.41%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%30.86%

3.2 Future

AVPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 111.91% yearly.
The Revenue is expected to grow by 23.13% on average over the next years. This is a very strong growth
EPS Next Y448.54%
EPS Next 2Y171.21%
EPS Next 3Y111.91%
EPS Next 5YN/A
Revenue Next Year24.13%
Revenue Next 2Y21.11%
Revenue Next 3Y20.77%
Revenue Next 5Y23.13%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AVPT Yearly Revenue VS EstimatesAVPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
AVPT Yearly EPS VS EstimatesAVPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 99.13, AVPT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of AVPT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.67. AVPT is valued rather expensively when compared to this.
AVPT is valuated quite expensively with a Price/Forward Earnings ratio of 40.43.
The rest of the industry has a similar Price/Forward Earnings ratio as AVPT.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.33, AVPT is valued quite expensively.
Industry RankSector Rank
PE 99.13
Fwd PE 40.43
AVPT Price Earnings VS Forward Price EarningsAVPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AVPT is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, AVPT is valued a bit cheaper than the industry average as 66.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 38.85
EV/EBITDA 94.57
AVPT Per share dataAVPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

AVPT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AVPT's earnings are expected to grow with 111.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y171.21%
EPS Next 3Y111.91%

0

5. Dividend

5.1 Amount

AVPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AVEPOINT INC

NASDAQ:AVPT (10/23/2025, 8:00:01 PM)

Premarket: 14.96 +0.09 (+0.61%)

14.87

+0.18 (+1.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/amc
Inst Owners64.04%
Inst Owner Change-0.12%
Ins Owners32.58%
Ins Owner Change0.96%
Market Cap3.15B
Revenue(TTM)373.07M
Net Income(TTM)-8427000
Analysts81.18
Price Target22.13 (48.82%)
Short Float %4.18%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.81%
Min EPS beat(2)8.93%
Max EPS beat(2)26.69%
EPS beat(4)3
Avg EPS beat(4)-31.57%
Min EPS beat(4)-180.31%
Max EPS beat(4)26.69%
EPS beat(8)6
Avg EPS beat(8)8.65%
EPS beat(12)8
Avg EPS beat(12)-44.31%
EPS beat(16)10
Avg EPS beat(16)-220.68%
Revenue beat(2)2
Avg Revenue beat(2)3.57%
Min Revenue beat(2)2.91%
Max Revenue beat(2)4.23%
Revenue beat(4)3
Avg Revenue beat(4)2.71%
Min Revenue beat(4)-0.69%
Max Revenue beat(4)4.41%
Revenue beat(8)7
Avg Revenue beat(8)2.38%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)11
Avg Revenue beat(16)0.68%
PT rev (1m)-0.86%
PT rev (3m)4.76%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-8.46%
EPS NY rev (1m)0.83%
EPS NY rev (3m)1.47%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.84%
Valuation
Industry RankSector Rank
PE 99.13
Fwd PE 40.43
P/S 8.45
P/FCF 38.85
P/OCF 36.75
P/B 7.11
P/tB 8.02
EV/EBITDA 94.57
EPS(TTM)0.15
EY1.01%
EPS(NY)0.37
Fwd EY2.47%
FCF(TTM)0.38
FCFY2.57%
OCF(TTM)0.4
OCFY2.72%
SpS1.76
BVpS2.09
TBVpS1.85
PEG (NY)0.22
PEG (5Y)N/A
Graham Number2.66
Profitability
Industry RankSector Rank
ROA -1.2%
ROE -1.9%
ROCE 4.85%
ROIC 3.83%
ROICexc 43.3%
ROICexgc N/A
OM 6.13%
PM (TTM) N/A
GM 74.93%
FCFM 21.74%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 78.62%
Cap/Sales 1.24%
Interest Coverage 250
Cash Conversion 298.03%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z 7.5
F-Score6
WACC10.97%
ROIC/WACC0.35
Cap/Depr(3y)70.47%
Cap/Depr(5y)101.2%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y448.54%
EPS Next 2Y171.21%
EPS Next 3Y111.91%
EPS Next 5YN/A
Revenue 1Y (TTM)24.41%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%30.86%
Revenue Next Year24.13%
Revenue Next 2Y21.11%
Revenue Next 3Y20.77%
Revenue Next 5Y23.13%
EBIT growth 1Y579.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.33%
EBIT Next 3Y41.69%
EBIT Next 5YN/A
FCF growth 1Y539.73%
FCF growth 3Y222.06%
FCF growth 5YN/A
OCF growth 1Y468.22%
OCF growth 3Y160.48%
OCF growth 5YN/A